<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03331302</url>
  </required_header>
  <id_info>
    <org_study_id>20053</org_study_id>
    <nct_id>NCT03331302</nct_id>
  </id_info>
  <brief_title>Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy</brief_title>
  <official_title>Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy&#xD;
      to detect defects in lung ventilation from airflow limitation. This study is conducted as a&#xD;
      pilot study with intention to conduct a larger clinical trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperpolarized Xenon-129 MRI has been developed by a number of techniques for imaging the&#xD;
      lung that provide information about various aspects of lung function and structure. The main&#xD;
      objective of this pilot study is to test and optimize the imaging parameters for a future&#xD;
      industry sponsored clinical trial. The goal of the future trial is to determine the&#xD;
      concordance between hyperpolarized xenon-129 ventilation MR imaging and nuclear medicine&#xD;
      ventilation imaging (Gold Standard). In this study we will test the imaging parameters and&#xD;
      techniques. We will directly compare human ventilation lung images in subjects with COPD,&#xD;
      using nuclear medicine ventilation imaging with Xenon-133 gas scintigraphy versus&#xD;
      hyperpolarized xenon-129 gas MRI. Our hypothesis is that current Xe-133 scintigraphy, which&#xD;
      uses a radioactive gas (Xe-133) and produces a projection image of the lungs with relatively&#xD;
      poor resolution, will not be able to detect small lung ventilation obstructions, which can be&#xD;
      detected using hyperpolarized Xe-129 gas MRI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>COPD patients with standard vs study diagnostic methods (imaging procedures)</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilation imaging resolution comparison between MRI and scintigraphy</measure>
    <time_frame>12 months</time_frame>
    <description>Compare the quality of the imaging between hyper polarized xenon-129 and radioactive xenon-133</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>COPD patients - Xe-133</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>COPD patients who will be assessed with Xenon-133 scintigraphy (Standard diagnostic study)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD patients - Hyperpolarized Xe-129</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients crossed over from the Active Comparator Arm who will be assessed with hyper polarized Xenon-129 MRI (Experimental diagnostic study)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyperpolarized Xenon-129 MRI (Experimental)</intervention_name>
    <description>MRI ventilation scan of the lung with inhaled contrast agent (hyperpolarized Xenon-129)</description>
    <arm_group_label>COPD patients - Hyperpolarized Xe-129</arm_group_label>
    <other_name>Polarean Pilot study</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Radioactive Xenon-133 scintigraphy (Active Comparator)</intervention_name>
    <description>Radioactive ventilation scintigraphy of the lung with inhaled radioactive contrast agent (Xenon-133)</description>
    <arm_group_label>COPD patients - Xe-133</arm_group_label>
    <other_name>Pilot study</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects must have a diagnosis of COPD&#xD;
&#xD;
          -  at their clinical baseline on the day of imaging&#xD;
&#xD;
          -  must be clinically stable in order to participate in the study.&#xD;
&#xD;
          -  COPD subjects will be categorized according to the GOLD&#xD;
&#xD;
          -  Current/Former SmokerSubjects&#xD;
&#xD;
          -  must have a smoking history â‰¥ 10 pack years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dx of asthma&#xD;
&#xD;
          -  Continuous oxygen use at home&#xD;
&#xD;
          -  Blood oxygen saturation of 92% less than as measured by pulse oximetry on the day of&#xD;
             imaging&#xD;
&#xD;
          -  FEV1 percent predicted less than 25%&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Claustrophobia, inner ear implants, aneurysm or other surgical clips, metal foreign&#xD;
             bodies in eye, pacemaker or other contraindication to MR scanning&#xD;
&#xD;
          -  Subjects with any implanted device that cannot be verified as MRI compliant will be&#xD;
             excluded&#xD;
&#xD;
          -  Chest circumference greater than that of the xenon MR and/or helium coil. The&#xD;
             circumference of the coil is approximately 42 inches&#xD;
&#xD;
          -  History of congenital cardiac disease, chronic renal failure, or cirrhosis&#xD;
&#xD;
          -  Inability to understand simple instructions or to hold still for approximately 10&#xD;
             seconds&#xD;
&#xD;
          -  History of respiratory infection within 2 weeks prior to the MR scan&#xD;
&#xD;
          -  History of MI, stroke and/or poorly controlled hypertension.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yun M Shim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Struchen, RN</last_name>
    <phone>4342436074</phone>
    <email>SS8YM@hscmail.mcc.virginia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roselove Nunoo-Asare, RT</last_name>
    <phone>4342437363</phone>
    <email>RNN3B@hscmail.mcc.virginia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Struchen, RN</last_name>
      <phone>434-243-6074</phone>
      <email>SS8YM@hscmail.mcc.virginia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Roselove Nunoo-Asare, RT</last_name>
      <phone>434-243-6074</phone>
      <email>RNN3B@hscmail.mcc.virginia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mike Shim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 31, 2017</study_first_submitted>
  <study_first_submitted_qc>October 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Y. Michael Shim, MD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Xenon</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Undecided for now.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

